NYU physics professor David Grier awarded $200,000 from the NSF RAPID fund to develop platform for diagnosing viral infection
The shortage of available coronavirus testing—and the cumbersome process these tests entail—has hampered the ability of American doctors to track the disease and ensure isolation among infected individuals. Fortunately, NYU physics professor David Grier had already developed and patented technology for holographic protein binding that may form the basis for a highly accurate, easily administered, fast, and affordable test for SARS-CoV-2 (coronavirus). Last week, Grier was awarded $200,000 from the NSF RAPID fund to develop this platform for diagnosing viral infection. The funding will also cover the costs of the supplies needed to do the work using existing equipment.